Evaluation Of The Prognostic And Predictive Value Of Tumor-Infiltrating Lymphocytes (Tils) In A Phase Iii Randomized Adjuvant Breast Cancer (Bc) Trial (Big 2-98) Of Node-Positive (N Plus ) Bc Comparing The Addition Of Docetaxel To Doxorubicin (A-T) With Doxorubicin (A)-Only Chemotherapy (Ct).